Close



Apr 2, 2024 07:04AM
Apr 2, 2024 07:00AM
Aug 1, 2023 07:00AM
Aug 1, 2023 07:00AM
Mar 24, 2023 04:01PM
Mar 16, 2023 07:00AM
Nov 15, 2022 07:00AM Bio-Path Holdings Reports Third Quarter 2022 Financial Results
Nov 8, 2022 07:00AM
Nov 7, 2022 07:01AM
Nov 7, 2022 07:00AM
Sep 6, 2022 07:00AM
Aug 16, 2022 07:00AM
Aug 9, 2022 07:00AM
May 17, 2022 07:00AM Bio-Path Holdings Reports First Quarter 2022 Financial Results
May 10, 2022 07:00AM
Apr 12, 2022 04:02PM
Apr 12, 2022 04:01PM
Apr 6, 2022 07:04AM
Apr 6, 2022 07:00AM
Mar 11, 2022 07:05AM
Mar 11, 2022 07:00AM Bio-Path Holdings Reports Full Year 2021 Financial Results
Mar 8, 2022 04:30PM
Mar 4, 2022 07:00AM
Jan 5, 2022 07:00AM
Dec 13, 2021 07:00AM
Nov 12, 2021 07:00AM
Oct 27, 2021 07:00AM
Aug 24, 2021 07:06AM Bio-Path Holdings (BPTH) Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients
Aug 24, 2021 07:00AM
Aug 13, 2021 07:00AM
Aug 6, 2021 07:00AM
Jun 22, 2021 07:12AM
Jun 22, 2021 07:00AM
May 14, 2021 07:00AM
May 7, 2021 07:00AM Bio-Path Holdings to Announce First Quarter 2021 Financial Results on May 14, 2021
Apr 22, 2021 07:00AM
Apr 12, 2021 07:00AM
Apr 5, 2021 07:01AM
Apr 5, 2021 07:00AM
Mar 11, 2021 07:00AM
Mar 10, 2021 07:00AM
Mar 3, 2021 04:01PM Bio-Path Holdings to Announce Full Year 2020 Financial Results on March 10, 2021
Feb 18, 2021 04:01PM
Feb 16, 2021 09:28AM
Feb 16, 2021 07:18AM
Feb 16, 2021 07:15AM
Feb 13, 2021 07:00AM
Feb 10, 2021 07:15AM
Feb 10, 2021 07:00AM Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Nov 19, 2020 07:07AM

251,009 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All